Upgrade to SI Premium - Free Trial

Form SC 13D/A Medley Capital Corp Filed by: Taube Brook

March 1, 2018 4:00 PM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13D

(Rule 13d-101)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

Rule 13d-2(a)

 

(Amendment No. 1)*

 

Under the Securities Exchange Act of 1934

 

  Medley Capital Corporation  
  (Name of Issuer)  
     
  Common Stock, $0.001 Par Value  
  (Title of Class of Securities)  
     
  58503F 304  
  (CUSIP Number)  
     
  Brook Taube  
  Medley LLC  
  280 Park Avenue, 6th Floor East  
  New York, NY 10017  
  (212) 759-0777  
  (Name, Address and Telephone Number of Person  
  Authorized to Receive Notices and Communications)  
     
  May 15, 2017  
  (Date of Event Which Requires Filing of This Statement)  

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rules 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ¨

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

  

 1 

 

 

 

CUSIP No. 58503F 304 13D Page 2 of 10 Pages

 

1

Name of Reporting Person/

I.R.S. Identification No. of Above Person (Entities Only)

Medley Seed Funding I LLC 

2 Check the Appropriate Box if a Member of a Group (a)  ¨
(b)  ¨
3 SEC Use Only
4 Source of Funds (See Instructions) WC
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) ¨  
6 Citizenship or Place of Organization Delaware

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7 Sole Voting Power 0
8 Shared Voting Power 7,756,938*
9 Sole Dispositive Power 0
10 Shared Dispositive Power 7,756,938*

11 Aggregate Amount Beneficially Owned by Each Reporting Person 7,756,938
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
(See Instructions)
13 Percent of Class Represented by Amount in Row (11) 14.24%**
14 Type of Reporting Person CO

 

* Based upon information contained in each Form 4 filed by Brook Taube and Seth Taube on July 12, 2017.

 

** The denominator is based on the 54,474,211 shares of common stock of Medley Capital Corporation outstanding as of February 5, 2018.

 

 2 

 

 

CUSIP No. 58503F 304 13D Page 3 of 10 Pages

 

1

Name of Reporting Person/

I.R.S. Identification No. of Above Person (Entities Only)

Medley LLC

 

2 Check the Appropriate Box if a Member of a Group (a)  ¨
(b)  ¨
3 SEC Use Only
4 Source of Funds (See Instructions) WC
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) ¨  
6 Citizenship or Place of Organization Delaware

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7 Sole Voting Power 0
8 Shared Voting Power 7,756,938*
9 Sole Dispositive Power 0
10 Shared Dispositive Power 7,756,938*

11 Aggregate Amount Beneficially Owned by Each Reporting Person 7,756,938
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
(See Instructions)
13 Percent of Class Represented by Amount in Row (11) 14.24%**
14 Type of Reporting Person CO

 

* These shares are deemed to be beneficially owned by Medley LLC, which has discretionary power over such shares as the managing member of Medley Seed Funding I LLC. Based upon information contained in each Form 4 filed by Brook Taube and Seth Taube on July 12, 2017.

 

** The denominator is based on the 54,474,211 shares of common stock of Medley Capital Corporation outstanding as of February 5, 2018.

 

 3 

 

 

CUSIP No. 58503F 304 13D Page 4 of 10 Pages

 

1

Name of Reporting Person/

I.R.S. Identification No. of Above Person (Entities Only)

 

Medley Management Inc.

 

2 Check the Appropriate Box if a Member of a Group (a)  ¨
(b)  ¨
3 SEC Use Only
4 Source of Funds (See Instructions) WC
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) ¨  
6 Citizenship or Place of Organization Delaware

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7 Sole Voting Power 0
8 Shared Voting Power 7,756,938*
9 Sole Dispositive Power 0
10 Shared Dispositive Power 7,756,938*

11 Aggregate Amount Beneficially Owned by Each Reporting Person 7,756,938
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
(See Instructions)
13 Percent of Class Represented by Amount in Row (11) 14.24%**
14 Type of Reporting Person CO

 

* These shares are deemed to be beneficially owned by Medley Management Inc., a holding company whose sole asset is its controlling equity interest in Medley LLC, which in turn controls Medley Seed Funding I LLC. Based upon information contained in each Form 4 filed by Brook Taube and Seth Taube on July 12, 2017.

 

** The denominator is based on the 54,474,211 shares of common stock of Medley Capital Corporation outstanding as of February 5, 2018.

 

 4 

 

 

 

 CUSIP No. 58503F 304 13D Page 5 of 10 Pages

 

1

Name of Reporting Person/

I.R.S. Identification No. of Above Person (Entities Only)

 

Medley Group LLC

 

2 Check the Appropriate Box if a Member of a Group (a)  ¨
(b)  ¨
3 SEC Use Only
4 Source of Funds (See Instructions) WC
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) ¨  
6 Citizenship or Place of Organization Delaware

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7 Sole Voting Power 0
8 Shared Voting Power 7,756,938*
9 Sole Dispositive Power 0
10 Shared Dispositive Power 7,756,938*

11 Aggregate Amount Beneficially Owned by Each Reporting Person 7,756,938
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
(See Instructions)
13 Percent of Class Represented by Amount in Row (11) 14.24%**
14 Type of Reporting Person CO

 

* These shares are deemed to be beneficially owned by Medley Group LLC, which has discretionary power over such shares in light of its controlling interest in Medley LLC, the managing member of Medley Seed Funding I LLC. Based upon information contained in each Form 4 filed by Brook Taube and Seth Taube on July 12, 2017.

 

** The denominator is based on the 54,474,211 shares of common stock of Medley Capital Corporation outstanding as of February 5, 2018.

 

 5 

 

 

 CUSIP No. 58503F 304 13D Page 6 of 10 Pages

 

1

Name of Reporting Person/

I.R.S. Identification No. of Above Person (Entities Only)

 

Brook Taube

 

2 Check the Appropriate Box if a Member of a Group (a)  ¨
(b)  ¨
3 SEC Use Only
4 Source of Funds (See Instructions) OO; PF
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) ¨  
6 Citizenship or Place of Organization United States

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7 Sole Voting Power 190,000*
8 Shared Voting Power 7,756,938**
9 Sole Dispositive Power 190,000*
10 Shared Dispositive Power 7,756,938**

11 Aggregate Amount Beneficially Owned by Each Reporting Person 7,946,938
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
(See Instructions)
13 Percent of Class Represented by Amount in Row (11) 14.59%***
14 Type of Reporting Person IN

 

*     These shares are held by a trust for the benefit of the Reporting Person's family, for which the Reporting Person serves as a trustee. Based upon information contained in the Form 4 filed by Brook Taube on July 12, 2017.

 

**   These shares are deemed to be beneficially owned by Brook Taube as a result of his discretionary power over such shares due to his status as a controlling person of Medley LLC, the managing member of Medley Seed Funding I LLC. Based upon information contained in the Form 4 filed by Brook Taube on July 12, 2017.

 

***  The denominator is based on the 54,474,211 shares of common stock of Medley Capital Corporation outstanding as of February 5, 2018.

 

 6 

 

 

 CUSIP No. 58503F 304 13D Page 7 of 10 Pages

 

1

Name of Reporting Person/

I.R.S. Identification No. of Above Person (Entities Only)

 

Seth Taube

 

2 Check the Appropriate Box if a Member of a Group (a)  ¨
(b)  ¨
3 SEC Use Only
4 Source of Funds (See Instructions) OO; PF
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) ¨  
6 Citizenship or Place of Organization United States

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7 Sole Voting Power 177,510*
8 Shared Voting Power 7,756,938**
9 Sole Dispositive Power 177,510*
10 Shared Dispositive Power 7,756,938**

11 Aggregate Amount Beneficially Owned by Each Reporting Person 7,934,448
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
(See Instructions)
13 Percent of Class Represented by Amount in Row (11) 14.57%***
14 Type of Reporting Person IN

 

*       Includes 142,510 shares held by a trust for the benefit of the Reporting Person's family, for which the Reporting Person serves as a trustee, and 35,000 shares held by The Seth and Angie Taube Foundation, Inc., which is a 501(c)(3) charitable organization, for which the Reporting Person serves as a trustee. Based upon information contained in the Form 4 filed by Seth Taube on July 12, 2017.

 

**     These shares are deemed to be beneficially owned by Seth Taube as a result of his discretionary power over such shares due to his status as a controlling person of Medley LLC, the managing member of Medley Seed Funding I LLC. Based upon information contained in the Form 4 filed by Seth Taube on July 12, 2017.

 

***   The denominator is based on the 54,474,211 shares of common stock of Medley Capital Corporation outstanding as of February 5, 2018.

 

 7 

 

 

INTRODUCTORY NOTE

 

This Amendment No. 1 to Schedule 13D (this “Schedule 13D/A”) amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission on February 14, 2017 (the “Schedule 13D”) with respect to the common stock, par value $0.001 per share (the “Common Stock”), of Medley Capital Corporation (the “Issuer”). The principal executive office of the Issuer is 280 Park Avenue, 6th Floor East, New York, New York 10017. Unless otherwise indicated, each capitalized term used but not otherwise defined herein shall have the meaning assigned to such term in the Schedule 13D. Except as herein amended or supplemented, all other information in the Schedule 13D is as set forth therein.

 

Item 2. Identity and Background.

 

Item 2 of the Schedule 13D remains unchanged.

 

Item 3. Source and Amount of Funds or Other Consideration.

 
Item 3 of the Schedule 13D remains unchanged.

 

Item 4. Purpose of Transaction.

 

Item 4 of the Schedule 13D remains unchanged.

 

Item 5. Interest in Securities of the Issuer.

 

Items 5(a), 5(b), and 5(c) of the Schedule 13D are hereby amended and restated in their entirety as follows:

 

(a)            See Items 11 and 13 of the cover pages of this Schedule 13D, which Items are incorporated herein by reference, for the aggregate number of shares and percentage of the Common Stock identified pursuant to Item 1 beneficially owned by each of Medley Seed Funding I LLC, Medley LLC, Medley Management Inc. ("MDLY"), Medley Group LLC, Brook Taube and Seth Taube (together, the “Reporting Persons”).

  

(b)            See Items 7, 8, 9 and 10 of the cover pages to this Schedule 13D, which Items are incorporated herein by reference, for the aggregate number of shares of the Common Stock beneficially owned by each of the Reporting Persons as to which there is sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition of such shares of the Common Stock.

 

MDLY has a controlling equity interest in, and is the sole managing member of, Medley LLC. Medley Group LLC has a controlling equity interest in MDLY. Brook Taube and Seth Taube have a majority equity interest in, and each individually maintain a controlling interest in, Medley Group LLC.  As a result, Brook Taube and Seth Taube are both deemed to control MDLY, which in turn controls Medley LLC, which serves as the managing member of Seed Funding.

 

(c)           Since the filing of the Schedule 13D, Seed Funding conducted the following transactions in the Common Stock pursuant to the Plan. All transactions were conducted in the open market for cash. If the shares were purchased in multiple transactions in a single trading day, the price per share reported in the third column is the weighted average price. The aggregate sale price in column 4 does not reflect brokerage commissions paid. 

 8 

 

  

Date of Transaction  Number of Shares   Price per Share   Aggregate Sale Price 
03/07/2017   37,754   $7.4976   $283,064.3904 
03/08/2017   3,081   $7.50   $23,107.5 
03/09/2017   76,845   $7.4743   $574,362.5835 
03/13/2017   11,253   $7.4994   $84,390.7482 
03/14/2017   39,270   $7.50   $394,525 
03/15/2017   42,800   $7.5   $321,000 
03/16/2017   400   $7.50   $3,000 
03/17/2017   11,660   $7.50   $87,500 
05/09/2017   49,869   $6.8409   $341,148.8421 
05/10/2017   49,869   $6.1912   $308,748.9528 
05/11/2017   49,869   $6.1579   $307,088.3151 
05/12/2017   80,000   $6.175   $494,000 
05/15/2017   55,151   $6.1441   $338,853.2591 
05/16/2017   94,986   $6.1625   $585,351.225 
05/17/2017   101,376   $6.1518   $623,644.8768 
05/18/2017   101,376   $6.2349   $632,069.2224 
05/19/2017   101,376   $6.2157   $630,122.8032 
05/22/2017   133,549   $6.1482   $821,085.9618 
05/23/2017   124,927   $6.1313   $965,9664.9151 
05/24/2017   133,549   $6.106   $815,450.194 
05/25/2017   133,549   $6.0756   $811,390.3044 
05/26/2017   133,549   $6.0574   $808,959.7126 
05/30/2017   169,029   $6.104   $1,031,753.016 
05/31/2017   117,298   $6.1095   $716,632.131 
06/01/2017   169,029   $6.1367   $1,037,280.2643 
06/02/2017   169,029   $6.1246   $1,035,235.0134 
06/05/2017   194,967   $6.0781   $1,185,028.9227 
06/06/2017   194,967   $6.0587   $1,181,246.5629 
06/07/2017   194,967   $6.0924   $1,187,816.9508 
06/08/2017   194,967   $6.1466   $1,198,384.1622 
06/09/2017   194,967   $6.1374   $1,194,640.7958 
06/12/2017   162,212   $6.1755   $1,001,740.206 
06/13/2017   162,212   $6.2556   $1,014,733.3872 
06/14/2017   143,497   $6.2411   $895,579.1267 
06/15/2017   162,212   $6.2564   $1,014,863.1568 
06/16/2017   162,212   $6.3214   $1,025,406.9368 
06/19/2017   95,713   $6.3923   $611,826.2099 
06/20/2017   153,711   $6.3412   $974,712.1932 
06/21/2017   153,711   $6.2362   $958,572.5382 
06/22/2017   153,711   $6.2599   $962,215.4889 
06/23/2017   117,833   $6.3255   $745,352.6415 
06/26/2017   38,287   $6.3888   $244,607.9856 
06/27/2017   136,154   $6.3453   $863,937.9762 
06/28/2017   102,152   $6.3628   $649,972.7456 
06/29/2017   33,114   $6.3991   $211,899.7974 
06/30/2017   3,039   $6.40   $19,449.60 
07/03/2017   14,999   $6.40   $95,993.60 
07/05/2017   50,049   $6.40   $320,313.60 
07/06/2017   105,932   $6.3824   $676,100.3968 
07/07/2017   92,116   $6.3499   $584,927.3884 
07/10/2017   12,109   $6.3987   $77,481.8583 

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

Item 6 of the Schedule 13D remains unchanged.

 

Item 7. Material to be Filed as Exhibits.

 

Exhibit 7.01 Master Investment Agreement, dated as of June 3, 2016, among Medley LLC, Medley Seed Funding I LLC, Medley Seed Funding II LLC, Medley Seed Funding III LLC, DB MED Investor I LLC and DB MED Investor II LLC (incorporated by reference to Exhibit 10.11 to Medley LLC’s Registration Statement on Form S-1/A (File No. 333-212514) filed on July 28, 2016) (Incorporated by reference to Exhibit 7.01 to the Schedule 13D filed on February 13, 2017)
Exhibit 7.02 Joint Filing Agreement by and among the Reporting Persons, dated February 13, 2017 (Incorporated by reference to Exhibit 7.02 to the Schedule 13D filed on February 13, 2017).

 

 

 9 

 

 

SignatureS

 

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned Reporting Persons certifies that the information set forth in this statement with respect to him or it, as applicable, is true, complete and correct.

  

  MEDLEY LLC
     
  By: /s/ Brook Taube
    Name:  Brook Taube
    Title:  Co-Chief Executive Officer
     Date: March 1, 2018

 

  MEDLEY MANAGEMENT INC.
     
  By: /s/ Brook Taube
    Name:  Brook Taube
    Title:  Co-Chief Executive Officer
     Date: March 1, 2018

 

  MEDLEY GROUP LLC
   
  By: /s/ Brook Taube
    Name:  Brook Taube
    Title:  Chief Executive Officer
     Date: March 1, 2018

 

  MEDLEY SEED FUNDING I LLC
   
     By: Medley LLC, its Managing Member
     
  By: /s/ Brook Taube
    Name:  Brook Taube
    Title:  Co-Chief Executive Officer
     Date: March 1, 2018

 

  BROOK TAUBE
   
    /s/ Brook Taube
     Date: March 1, 2018
     
  SETH TAUBE
   
    /s/ Seth Taube
     Date: March 1, 2018

 

 

 10 

 

 

Categories

SEC Filings